Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
The Community Guide Home Page

Prevention of HIV/AIDS, other STIs and Pregnancy: Comprehensive Risk Reduction Interventions

Task Force Findings and Rationale Statement

Definition

Comprehensive Risk Reduction (CRR) promotes behaviors that prevent or reduce the risk of pregnancy, HIV, and other sexually transmitted infections (STIs). These interventions may: a) suggest a hierarchy of recommended behaviors, identifying abstinence as the “best,” or “preferred,” method but also providing information about sexual risk reduction strategies; b) promote abstinence and sexual risk reduction without placing one approach above another; or c) primarily or solely promote sexual risk reduction strategies. This review evaluated CRR interventions delivered in school or community settings to groups of adolescents (10-19 years old). These interventions may also include other components such as condom distribution and STI testing.

Finding

The Task Force recommends group-based comprehensive risk reduction (CRR) delivered to adolescents to promote behaviors that prevent or reduce the risk of pregnancy, HIV, and other sexually transmitted infections (STIs). The recommendation is based on sufficient evidence of effectiveness in: reducing a number of self-reported risk behaviors, including (1) engagement in any sexual activity, (2) frequency of sexual activity, (3) number of partners, and (4) frequency of unprotected sexual activity; (5) increasing the self-reported use of protection against pregnancy and STIs; and (6) reducing the incidence of self-reported or clinically-documented sexually transmitted infections. There is limited direct evidence of effectiveness, however, for reducing pregnancy and HIV.

Rationale

Our review identified 62 studies and 83 study arms that used a comprehensive risk reduction (CRR) strategy. The effect estimates from this review are of sufficient magnitude to support a conclusion that CRR interventions can have a beneficial effect on public health.

This review contains enough studies of adequate quality to support a recommendation based on strong evidence of effectiveness. However, the Task Force concluded that there is sufficient, rather than strong, evidence of effectiveness due to variations across studies in intervention effect estimates. The summary statistics for each outcome are listed in the table below:

Meta-Analysis Results: Comprehensive Risk Reduction

Outcomes a

# of observations

OR

95% CI

Estimated RR

Sexual Activity

57

0.84

0.75, 0.95

0.88

Frequency of Sexual Activity

14

0.81

0.72, 0.90

b

Number of Partners

28

0.83

0.74, 0.93

0.86

Unprotected Sexual Activity

29

0.70

0.60, 0.82

0.75

Protection c

63

1.39

1.19, 1.62

1.13

Condom Use c

48

1.45

1.20, 1.74

1.12

Oral Contraceptive Use c

10

1.29

0.89, 1.85

1.22

Dual Use c

5

1.21

0.70, 2.12

1.17

Sexually Transmitted Infections

8

0.65

0.47, 0.90

0.69

Pregnancy

11

0.88

0.60, 1.30

0.89

HIV

0

--

--

--

a All of these outcomes were self-reported, with the exception of STIs, which were either self reported or clinically documented.
b Unable to calculate
c ORs>1.0 indicate beneficial effects.

The evidence supports a conclusion that CRR interventions are applicable across a range of populations and settings. Studies included representation from a range of ages (mean min/max: 10-18 years); male only, female only and coed groups; majority African American, majority Caucasian, majority Hispanic and mixed race samples; both baseline virgin and non-virgin samples; and school and community settings. While the effects were generally similar for age, race/ethnicity, baseline virginity status and school and community settings, the results suggest that these interventions may be somewhat more effective for boys than girls. Although the overall results for STIs demonstrate similar beneficial effects in school and community settings, some caution is warranted in generalizing these STI results to low-risk populations in school settings because most of the evidence on this outcome comes from samples of adolescents at high risk for STIs who were recruited in clinical settings.

The implementation of the interventions varied in several potentially important ways, such as deliverer (peer or adult), whether they were targeted to group characteristics, focus (HIV, pregnancy or both) and the inclusion of other interventions in addition to CRR (e.g., condom distribution). There was no consistent evidence regarding the effects of any of these variables on the outcomes evaluated. However, the inability to detect such effects does not suggest that they are unimportant, and additional research to clarify the characteristics that maximize the effectiveness of CRR programs would be valuable.

All included studies were randomized controlled trials (RCTs) or controlled before- after (CBA) designs, and nearly all of the outcomes were self reported. Effects were generally similar for RCTs and CBA studies.

With regard to harms, no evidence was found in this review to support concerns regarding the potential for CRR interventions to result in an increase in sexual activity. To the contrary, the evidence indicated that CRR interventions reduce both prevalence of sexual activity and frequency of sexual activity.

JavaScript must be enabled to use the Text Sizer function.

The Guide to Clinical Preventive Services

Together, the Community Guide and the Clinical Guide provide evidence-based recommendations across the prevention spectrum.

More


Contact Us:
  • Community Guide Branch
    National Center for Health Marketing (NCHM)
    Centers for Disease Control and Prevention
    1600 Clifton Road NE
    Mailstop E-69
    Atlanta, GA 30333
  • Community Guide
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Community Guide Branch, National Center for Health Marketing (NCHM), Centers for Disease Control and Prevention,
1600 Clifton Rd NE, Mailstop E-69, Atlanta, GA 30333, U.S.A. communityguide@cdc.gov